How many studies have been conducted on Rituximab?

BiohacksAI has indexed 1,001 PubMed studies on Rituximab, including 359 randomized controlled trials (RCTs). 95% of studies involve human subjects.

What are the main research areas for Rituximab?

The primary research domains for Rituximab are 🛡️ Immunity, 🔬 Oncology, 😴 Sleep. This is based on analysis of 1,001 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Rituximab

A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.

1.0k+ PubMed studies analyzed · 359 RCTs · Evidence Score: 74.1

Research Domains

Rituximab has been studied across 11 research domains including 🛡️ Immunity, 🔬 Oncology, 😴 Sleep, 🦴 Bone & Joint, 🫘 Kidney. The primary research focus is 🛡️ Immunity with 23% of studies addressing this area.

Loading evidence profile...

This evidence profile for Rituximab is generated deterministically from 1,001 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.